상단 바로가기
본문 바로가기
하단 바로가기
국제심포지엄(IDRIC)
프로그램
발표자(좌장, 연자)소개
사전등록 신청
오시는 길
ENG
KOR
전체메뉴
국제심포지엄(IDRIC)
프로그램
발표자(좌장, 연자)소개
사전등록 신청
오시는 길
본문
서브비주얼
사전등록 신청
* 현장참여는 사전등록하신분에 한하여 참여가능합니다.
아래 항목을 입력해주세요.
* 필수 입력 사항
성명
*
소속
*
직책 / 직급
*
이메일
*
휴대폰
*
010
참가구분
*
온라인 참여
현장참여
* 현장참여는 사전등록하신분에 한하여 참여가능합니다.
2. 22(수)~23(목) - 전 일정 참여
2. 22(수) - Day1 만 참여
2. 23(목) - Day2 만 참여
- 국가별 또는 발표자에 대한 사전질의 내용은 현장에서 답변드립니다.
사전질의1 (선택)
질의할 세션을 선택해 주세요.
Session 1 (Virtual) : Building a novel pandemic preparedness program
Session 2 : Development of therapeutic human monoclonal antibodies against SFTSV infection
Session 3 : Bacteriophages and Endolysins Combating Multidrug Resistant (MDR) Pathogens
Session 4 : NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins
Session 5 : Research status of TLR5’s immune adjuvant
Session 6 : accine adjuvants research
Session 7 : The future of pandemic preparedness: Building collaborations and EV-D68 as a test case for NIAID/VRC's PREMISE program
(AM)Session 1 (Virtual) : One Health approach to antimicrobial resistance
(AM)Session 2 (Virtual) : One Health Antimicrobial Resistance research landscape in Singapore
(AM)Session 3 (Virtual) : Population CPE evolution in Singapore
(AM)Session 4 (Virtual) : Long Covid-19
(AM)Session 5 (Virtual) : Long COVID treatment trials: pathogenesis guides intervention
(PM)Session 1 (Virtual) : A research about national seroepidemiology and immunogenicity of people vaccinated against COVID-19
(PM)Session 2 (Virtual) : How to use and integrate whole genome sequencing into One Health AMR surveillance programmes
(PM)Session 3 : Development of the novel Tuberculosis vaccine applied to various platforms in Korea
(PM)Session 4 (Virtual) : Overview of TB vaccine development
사전질의2 (선택)
질의할 세션을 선택해 주세요.
Session 1 (Virtual) : Building a novel pandemic preparedness program
Session 2 : Development of therapeutic human monoclonal antibodies against SFTSV infection
Session 3 : Bacteriophages and Endolysins Combating Multidrug Resistant (MDR) Pathogens
Session 4 : NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins
Session 5 : Research status of TLR5’s immune adjuvant
Session 6 : accine adjuvants research
Session 7 : The future of pandemic preparedness: Building collaborations and EV-D68 as a test case for NIAID/VRC's PREMISE program
(AM)Session 1 (Virtual) : One Health approach to antimicrobial resistance
(AM)Session 2 (Virtual) : One Health Antimicrobial Resistance research landscape in Singapore
(AM)Session 3 (Virtual) : Population CPE evolution in Singapore
(AM)Session 4 (Virtual) : Long Covid-19
(AM)Session 5 (Virtual) : Long COVID treatment trials: pathogenesis guides intervention
(PM)Session 1 (Virtual) : A research about national seroepidemiology and immunogenicity of people vaccinated against COVID-19
(PM)Session 2 (Virtual) : How to use and integrate whole genome sequencing into One Health AMR surveillance programmes
(PM)Session 3 : Development of the novel Tuberculosis vaccine applied to various platforms in Korea
(PM)Session 4 (Virtual) : Overview of TB vaccine development
사전질의3 (선택)
질의할 세션을 선택해 주세요.
Session 1 (Virtual) : Building a novel pandemic preparedness program
Session 2 : Development of therapeutic human monoclonal antibodies against SFTSV infection
Session 3 : Bacteriophages and Endolysins Combating Multidrug Resistant (MDR) Pathogens
Session 4 : NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins
Session 5 : Research status of TLR5’s immune adjuvant
Session 6 : accine adjuvants research
Session 7 : The future of pandemic preparedness: Building collaborations and EV-D68 as a test case for NIAID/VRC's PREMISE program
(AM)Session 1 (Virtual) : One Health approach to antimicrobial resistance
(AM)Session 2 (Virtual) : One Health Antimicrobial Resistance research landscape in Singapore
(AM)Session 3 (Virtual) : Population CPE evolution in Singapore
(AM)Session 4 (Virtual) : Long Covid-19
(AM)Session 5 (Virtual) : Long COVID treatment trials: pathogenesis guides intervention
(PM)Session 1 (Virtual) : A research about national seroepidemiology and immunogenicity of people vaccinated against COVID-19
(PM)Session 2 (Virtual) : How to use and integrate whole genome sequencing into One Health AMR surveillance programmes
(PM)Session 3 : Development of the novel Tuberculosis vaccine applied to various platforms in Korea
(PM)Session 4 (Virtual) : Overview of TB vaccine development
개인정보 취급방침
"제1회 감염병연구기관 국제심포지엄(IDRIC)” 본 행사는 정보통신망 이용촉진 및 정보보호 등에 관한 법률 등 정보통신 서비스 제공자가 준수하여야 할 관련 법령상의 개인정보보호 규정을 준수하며, 관련 법령에 의거한 개인정보취급방침을 정하여 이용자 권익 보호에 최선을 다하고 있습니다. 행사에 관련된 개인정보를 수집, 이용목적 외에 다른 용도로 이를 이용하거나 이용자의 동의 없이 제 3자에게 이를 제공하지 않습니다.
위의 개인정보 취급 방침을 모두 읽었으며 동의합니다.
사전등록 신청
